Perfusion SPECT studies with mapping of Brodmann areas in differentiating Alzheimer's disease from frontotemporal degeneration syndromes

Nuclear Medicine Communications

Volumn 33, Issue 12, 2012, Pages 1267-1276

  Valotassiou, Varvara ^a   Papatriantafyllou, John ^b   Sifakis, Nikolaos ^c   Tzavara, Chara ^a   Tsougos, Ioannis ^a   Kapsalaki, Eftychia ^a   Hadjigeorgiou, George ^a   Georgoulias, Panagiotis ^a  

^a UNIVERSITY OF THESSALY   (Greece)

^b G GENNIMATAS GENERAL HOSPITAL   (Greece)

^c ALEXANDRA HOSPITAL   (Greece)

Author keywords

Alzheimer's disease; Brain perfusion imaging; Brodmann areas; Dementia; Frontotemporal degeneration syndromes; Single photon emission computed tomography

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN PERFUSION; CONTROLLED STUDY; CORTICOBASAL DEGENERATION; DIFFERENTIAL DIAGNOSIS; FEMALE; FRONTOTEMPORAL DEMENTIA; HUMAN; LEFT HEMISPHERE; MAJOR CLINICAL STUDY; MALE; OCCIPITAL CORTEX; PREDICTION; PROGRESSIVE NONFLUENT APHASIA; PROGRESSIVE SUPRANUCLEAR PALSY; RIGHT HEMISPHERE; SEMANTIC DEMENTIA; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TEMPORAL GYRUS;

AGED; ALZHEIMER DISEASE; BRAIN MAPPING; CEREBRAL CORTEX; DIAGNOSIS, DIFFERENTIAL; FEMALE; FRONTOTEMPORAL LOBAR DEGENERATION; HUMANS; IMAGING, THREE-DIMENSIONAL; MALE; PERFUSION IMAGING; ROC CURVE; SOFTWARE; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 84868610283     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/MNM.0b013e3283599983     Document Type: Article

References (59)

1. Mendez MF, Cummings JL. Dementia - a clinical approach. Philadelphia: Butterworth-Heinemann (Elsevier); 2003.
2. Harciarek M, Jodzio K. Neuropsychological differences between frontotemporal dementia and Alzheimer's disease: a review. Neuropsycol Rev 2005; 15:131-145.
3. Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 1998; 51:1546-1554.
4. Seelaar H, Rohrer JD, Pijnenburg YAL, Fox NC, van Swieten JC. Clinical, genetic and pathological heterogeneity of frontotemporal dementia: a review. J Neurol Neurosurg Psychiatry 2011; 82:476-486.
5. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34: 939-944.
6. Varma AR, Snowden JS, Lloyd JJ, Talbot PR, Mann DM, Neary D. Evaluation of the NINCDS-ADRDA criteria in the differentiation of Alzheimer's disease and frontotemporal dementia. J Neurol Neurosurg Psychiatry 1999; 66:184-188.
7. Siri S, Benaglio I, Frigerio A, Binetti G, Cappa SF. A brief neuropsychological assessment for the differential diagnosis between frontotemporal dementia and Alzheimer's disease. Eur J Neurol 2001; 8:125-132.
8. Jagust W. Molecular neuroimaging in Alzheimer's disease. NeuroRx 2004; 1:206-212.
9. Le Ber I, Guedj E, Gabelle A, Verpillat P, Volteau M, Thomas-Anterion C, et al. Demographic, neurological and behavioural characteristics and brain perfusion SPECT in frontal variant of frontotemporal dementia. Brain 2006; 129:3051-3065.
10. McNeill R, Sare GM, Manoharan M, Testa HJ, Mann DM, Neary D, et al. Accuracy of single-photon emission computed tomography in differentiating frontotemporal dementia from Alzheimer's disease. J Neurol Neurosurg Psychiatry 2007; 78:350-355.
11. O'Mahony D, Coffey J, Murphy J, O'Hare N, Hamilton D, Freyne P, et al. The discriminant value of semiquantitative SPECT data in mild Alzheimer's disease. J Nucl Med 1994; 35:1450-1455.
12. Talbot PR, Lloyd JJ, Snowden JS, Neary D, Testa HJ. Choice of reference region in the quantification of single-photon emission tomography in primary degenerative dementia. Eur J Nucl Med 1994; 21:503-508.
13. Begg CB, Gray R. Calculation of polychotomous logistic regression parameters using individualized regressions. Biometrika 1984; 71:11-18.
14. Kelley BJ, Petersen RC. Alzheimer's disease and mild cognitive impairment. Neurol Clin 2007; 25:577-609.
15. Rabinovici GD, Miller BL. Frontotemporal lobar degeneration. Epidemiology, pathophysiology, diagnosis and management. CNS Drugs 2010; 24: 375-398.
16. Honda N, Machida K, Matsumoto T, Machuda H, Imabayashi E, Hashimito J, et al. Three-dimentional stereotactic surface projection of brain perfusion SPECT improves diagnosis of Alzheimer's disease. Ann Nucl Med 2003; 17:641-648.
17. Varrone A, Pappata S, Caraco C, Soricelli A, Milan G, Quarantelli M, et al. Voxel-based comparison of rCBF SPET images in frontotemporal dementia and Alzheimer's disease highlights the involvement of different cortical networks. Eur J Nucl Med 2002; 29:1447-1454.
18. Acton PD, Friston KJ. Statistical parametric mapping in functional neuroimaging: beyond PET and fMRI activation studies. Eur J Nucl Med 1998; 25:663-667.
19. Imran MB, Kawashima R, Awata S, Sato K, Kinomura S, Ono S, et al. Parametric mapping of cerebral blood flow deficits in Alzheimer's disease: a SPECT study using HMPAO and image standardization technique. J Nucl Med 1999; 40:244-249.
20. Tranfaglia C, Palumbo B, Siepi D, Sinzinger H, Parnetti L. Semi-quantitative analysis of perfusion of Brodmann areas in the differential diagnosis of cognitive impairment in Alzheimer's disease, fronto-temporal dementia and mild cognitive impairment. Hell J Nucl Med 2009; 12:110-114.
21. Charpentier P, Lavenu I, Defebvre L, Duhamel A, Lecouffe P, Pasquier F, et al. Alzheimer's disease and frontotemporal dementia are differentiated by discriminant analysis applied to (99m)Tc-HmPAO SPECT data. J Neurol Neurosurg Psychiatry 2000; 69:661-663.
22. De Figueiredo RJ, Shankle WR, Maccato A, Dick MB, Mundkur P, Mena I, et al. Neural-network-based classification of cognitively normal, demented, Alzheimer disease and vascular dementia from single-photon emission with computed tomography image data from brain. Proc Natl Acad Sci USA 1995; 92:5530-5534.
23. Defebvre LJ, Leduc V, Duhamel A, Lecouffe P, Pasquier F, Lamy-Lhullier C, et al. Technetium-HMPAO SPECT study in dementia with Lewy-bodies, Alzheimer's disease and idiopathic Parkinson's disease. J Nucl Med 1999; 40:956-962.
24. Forman MS, Farmer J, Johnson JK, Clark CM, Arnold SE, Coslett HB, et al. Frontotemporal dementia: clinicopathological correlations. Ann Neurol 2006; 59:952-962.
25. Garraux G, Salmon E, Degueldre C, Lemaire C, Laureys S, Franck G. Comparison of impaired subcortico-frontal metabolic networks in normal aging, subcortico-frontal dementia, and cortical frontal dementia. Neuroimage 1999; 10:149-162.
26. Pickut BA, Saerens J, Mariën P, Borggreve F, Goeman J, Vandevivere J, et al. Discriminative use of SPECT in frontal lobe-type dementia versus (senile) dementia of the Alzheimer's type. J Nucl Med 1997; 38:929-934.
27. Ibach B, Poljansky S, Marienhagen J, Sommer M, Männer P, Hajak G. Contrasting metabolic impairment in frontotemporal degeneration and early onset Alzheimer's disease. Neuroimage 2004; 23:739-743.
28. Kaneko K, Kuwabara Y, Sasaki M, Ogomori K, Ichimiya A, Koga H, et al. Posterior cingulate hypoperfusion in Alzheimer's disease, senile dementia of Alzheimer type, and other dementias evaluated by three-dimensional stereotactic surface projections using Tc-99m HMPAO SPECT. Clin Nucl Med 2004; 29:362-366.
29. Kramer JH, Jurik J, Sha SJ, Rankin KP, Rosen HJ, Johnson JK, et al. Distinctive neuropsychological patterns in frontotemporal dementia, semantic dementia, and Alzheimer disease. Cogn Behav Neurol 2003; 16:211-218.
30. Hornberger M, Piguet O, Graham A, Nestor PJ, Hodges Jr. How preserved is episodic memory in behavioural variant frontotemporal dementia? Neurology 2010; 74:472-479.
31. Hornberger M, Savage S, Hsieh S, Mioshi E, Piguet O, Hodges Jr. Orbitofrontal dysfunction discriminates behavioural variant frontotemporal dementia from Alzheimer's disease. Dement Geriatr Cogn Disord 2010; 30:547-552.
32. Sinnatamby R, Antoun NA, Freer CE, Miles KA, Hodges Jr. Neuroradiological findings in primary progressive aphasia: CT, MRI and cerebral perfusion SPECT. Neuroradiology 1996; 38:232-238.
33. Soriani-Lefevre MH, Hannequin D, Bakchine S, Menard JF, Manrique A, Hitze A, et al. Evidence of bilateral temporal lobe involvement in primary progressive aphasia: a SPECT study. J Nucl Med 2003; 44:1013-1022.
34. Tyrrell PJ, Warrington EK, Frackowiak RS, Rossor MN. Heterogeneity in progressive aphasia due to focal cortical atrophy: a clinical and PET study. Brain 1990; 113:1321-1336.
35. Hodges JR, Patterson K, Oxbury S, Funnell E. Semantic dementia: progressive fluent aphasia with temporal lobe atrophy. Brain 1992; 115:1783-1806.
36. Mummery CJ, Patterson K, Price CJ, Ashburner J, Frackowiak RSJ, Hodges Jr. A voxel-based morphometry study of semantic dementia: the relationship between temporal lobe atrophy and semantic dementia. Ann Neurol 2000; 47:36-45.
37. Harasty JA, Halliday GM, Code C, Brooks WS. Quantification of cortical atrophy in a case of progressive fluent aphasia. Brain 1996; 119:181-190.
38. Graham KS, Hodges Jr. Differentiating the roles of the hippocampal complex and the neocortex in long-term memory storage: evidence from the study of semantic dementia and Alzheimer's disease. Neuropsychology 1997; 11:77-89.
39. Galton CJ, Gomez-Anson B, Antoun N, Scheltens P, Patterson K, Graves M, et al. J Neurol Neurosurg Psychiatry 2001; 70:165-173.
40. Chan D, Fox NC, Scahill RI, Crum WR, Whitwell JL, Leschziner G, et al. Patterns of temporal lobe atrophy in semantic dementia and Alzheimer's disease. Ann Neurol 2001; 49:433-442.
41. Snowden JS, Neary D, Mann DMA. Frontotemporal lobar degeneration: frontotemporal dementia, progressive aphasia, semantic dementia. New York: Churchill Livingstone; 1996.
42. Mummery CJ, Patterson K,Wise RJ, Vandenbergh R, Price CJ, Hodges Jr. Disrupted temporal lobe connections in semantic dementia. Brain 1999; 122:61-73.
43. Suh MK, Kim EJ, Lee BH, Seo SW, Chin J, Kang SJ, et al. Hanja (Ideogram) alexia and agraphia in patients with semantic dementia. Neurocase 2010; 16:146-156.
44. Cappa SF, Perani D, Messa C, Miozzo A, Fazio F. Varieties of progressive non-fluent aphasia. Ann N Y Acad Sci 1996; 777:243-248.
45. Perneczky R, Diehl-Schmid J, Pohl C, Drzezga A, Kurz A. Non-fluent progressive aphasia: cerebral metabolic patterns and brain reserve. Brain Res 2007; 1133:178-185.
46. Nestor PJ, Graham NL, Fryer TD, Williams GB, Patterson K, Hodges Jr. Progressive non-fluent aphasia is associated with hypometabolism centred on the left anterior insula. Brain 2003; 126:2406-2418.
47. Turner RS, Kenyon LC, Trojanowski JQ, Gonatas N, Grossman M. Clinical, neuroimaging, and pathologic features of progressive nonfluent aphasia. Ann Neurol 1996; 39:166-173.
48. Greene JD, Patterson K, Xuereb J, Hodges Jr. Alzheimer disease and nonfluent progressive aphasia. Arch Neurol 1996; 53:1072-1078.
49. Hodges RJ, Patterson K. Nonfluent progressive aphasia and semantic dementia: a comparative neuropsychological study. J Int Neuropsychol Soc 1996; 2:511-524.
50. Caselli RJ, Jack CR, Petersen RC, Wahner HW, Yanagihara T. Asymmetric cortical degenerative syndromes: clinical and radiological correlations. Neurology 1992; 42:1462-1468.
51. Josephs KA, Duffy JR, Strand EA, Whitwell JL, Layton KF, Parisi JE, et al. Clinicopathological and imaging correlates of progressive aphasia and apraxia of speech. Brain 2006; 129:1385-1398.
52. Bennett DA, Schneider JA,Wilson RS, Bienias JL, Arnold SE. Neurofibrillary tangles mediate the association of amyloid load with clinical Alzheimer disease and level of cognitive function. Arch Neurol 2004; 61:378-384.
53. Dickson DW. Neuropathologic differentiation of progressive supranuclear palsy and corticobasal degeneration. J Neurol 1999; 246:6-15.
54. Graham NL, Bak TH, Hodges Jr. Corticobasal degeneration as a cognitive disorder. Mov Disord 2003; 18:1224-1232.
55. Slawek J, Derejko M, Dubaniewicz M. Cerebral blood flow SPECT may be helpful in establishing the diagnosis of progressive supranuclear palsy and corticobasal degeneration. Nucl Med Rev Cent East Eur 2001; 4:73-76.
56. Hossain AK, Murata Y, Zhang L, Taura S, Saitoh Y, Mizusawa H, et al. Brain perfusion SPECT in patients with corticobasal degeneration: analysis using statistical parametric mapping. Mov Disord 2003; 18:697-703.
57. Turjanski N, Brooks DJ. PET and the investigation of dementia in the parkinsonian patient. J Neural Transm Suppl 1997; 51:37-48.
58. Teune LK, Bartels AL, de Jong BM, Willemsen AT, Eshuis SA, de Vries JJ, et al. Typical cerebral metabolic patterns in neurodegenerative brain diseases. Mov Disord 2010; 25:2395-2404.
59. Juh R, Pae CU, Kim TS, Lee CU, Choe B, Suh T. Cerebral glucose metabolism in corticobasal degeneration comparison with progressive supranuclear palsy using statistical mapping analysis. Neurosci Lett 2005; 383:22-27.